INCLUDE_DATA
Stan Gardner M.D.
Stan Gardner M.D.
Sign up for our free report Sign up for the email newsletter! "Comparison of Alternative Medicine and Conventional Medicine" and daily health secrets.

Stomach and Bone Challenges

May 19th, 2010 · 9:46 AM

I have had a gastrectomy and osteoporosis. I have been prescribed Fosamax, but I refuse to take it. What else can I do?
You have no stomach, so your food will not be churned, nor will it be exposed to high acid, which is needed for some foods to be broken down, especially [...]

[Read more →]

Tags: , , , ,

Safe Treatments for Osteoporosis

April 7th, 2010 · 5:23 AM

What about once a month Boniva?  Does it fit in the category of a safe treatment for osteoporosis?
Boniva, Actonel and Fosamax are in a category of medications call bisphosphonates. They interfere with the repair of bones.
Bones are live tissue, like any other tissue in the body. When bone tissue needs repair, osteoclasts are sent [...]

[Read more →]

Tags: , , , ,

Vitamin D Deficiency and Bone Loss (Osteoporosis)

February 1st, 2010 · 9:15 AM

I am 72, and have developed Osteomalacia (an adult form of Rickets) from a vitamin D deficiency, which has been treated and is now better. I also have the beginning of Osteoporosis and am struggling to learn how to treat myself. How do I find out just how much of all the minerals I need [...]

[Read more →]

Tags: , , , , ,

Hormone Replacement Therapy: Risks and Reliable Information

March 7th, 2009 · 10:45 AM

The 7 Things You Should Know About Hormones

The Health Journal section of the Wall Street Journal describes mainstream thinking on hormones and concerns with the recent “Oprah Winfrey Show” with Suzanne Somers. Melinda Beck, author of the article, recites the following mainstream thinking:
1) ‘Bio-identical’ hormones are

[Read more →]

Tags: , , , , , , , , , ,

Postmenopausal Women and Osteoporosis: New “Safe” Drug?

September 15th, 2008 · 8:25 PM

Forbes shared this information:  Pharmaceutical Company Pfizer is trying to clear another medication to treat osteoporosis in postmenopausal women. This is the third time this drug has been submitted—the first two times it was rejected because 1) there is an increased risk

[Read more →]

Tags: , , , , , , ,